-- Another successful outcome from the firm’s commitment to San Diego -- -- Builds on pipeline of start-ups developing better cancer therapies aimed at previously intractable targets -- SAN DIEGO--(BUSINESS WIRE)--Versant Ventures today announced that
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the second quarter ended June 30, 2021. “The second h
MEDFORD, Ore.--(BUSINESS WIRE)--Grown Rogue International Inc. (“Grown Rogue” or the “Company”) (CSE: GRIN) (OTC: GRUSF), a multi-state cannabis company with operations and assets in Oregon and Michigan, today announced record revenues for its Mic
Frederic Ors to Step Down as CEO CBO Andrew Hall Appointed Interim CEO Board Initiating Search for Permanent Successor DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq:IMV; TSX:IMV) (“IMV” or the “Company”), a clinical-stage biopharmac
Dr. Barry Duplantis, Ph.D., promoted to VP of Client Relations Carla Dahl, appointed to VP of Marketing VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VEN
Collaboration leverages AbCellera’s AI-powered technology platform to identify novel antibody drug candidates for multiple disease targets across several therapeutic areas coupled with EQRx’s innovative model to accelerate the delivery and patient ac
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LL
MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, fo
BURLINGTON, Ontario--(BUSINESS WIRE)--$ANRG #Anaergia--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today the acquisition of its indirect subsidiary, Rhode Island Bioenergy Facility, LLC (fka Orbit Energy Rhode Island, LLC), w
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB: CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therape
Game Changers is the first report to compile Canada’s extensive activity in alternative protein development in one place.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.